Information on TPP2
Basic details
Alt. symbols: TPPII
Approved name: tripeptidyl peptidase 2
Alt. names: tripeptidyl peptidase II
Location: 13q33.1: 102596958 - 102679958 (+)
Gene type: protein_coding, 29 transcripts.
Scores: LoFtool: 0.066600 | pLI: 0.99986319 | LOEUF: 0.263
Normal function
TPP2 encodes a ubiquitously expressed cytosolic protease involved in protein degradation. The enzyme removes tripeptides from the N-terminal end of longer peptides to help in the elimination of proteins downstream of the proteasome-ubiquitin degradation pathway. This also contributes to the maintenance of free amino acid pools for protein synthesis. TPP2 has also been implicated in stimulation of adipogenesis and the generation of thymic self-peptides and degradation of MHC class I epitopes, suggesting a role in immune function. It may be able to complement 26S proteasome function to some extent under conditions in which the latter is inhibited.
Dysfunction and disease
Biallelic mutations in TPP2 are associated with Immunodeficiency-78 with autoimmunity and developmental delay (IMD78) [MIM: 619220], an autosomal recessive systemic disorder characterized by immune dysregulation in the form of both immunodeficiency - featuring recurrent sinopulmonary or skin infections and increased susceptibility to bacterial, viral, and fungal infections - and autoimmunity, particularly cytopenias but also autoimmune hepatitis or thyroid disease, and CNS involvement with multi ple sclerosis-like sterile inflammation or vasculitis with stroke (PMID: 25414442, 30533531, 33586135). Laboratory studies show lymphopenia with advanced differentiation and premature senescence of CD8+ T cells and B cells; many patients show autoantibody production and some have hypergammaglobulinemia. Skin, hair and nail findings as well as developmental delays and variable intellectual disability may also be present. Many patients die prematurely, but successful hematopoietic bone marrow transplant may be curative. [Load More]
[Reviewed by Xiao P. Peng on 2021-06-07 10:09:38]
Associated conditions
Please mind that full curation (inclusion of all published patients) of this gene has not started yet. Please contact us if you want to volunteer.
Transcripts of TPP2
Name | ENSEMBL_ID | LRG_ID | CCDS_ID | MANE | Transcript.type | Exons | Canonical | CDS_length | REFSEQ_ID |
---|---|---|---|---|---|---|---|---|---|
201 | ENST00000376052.5 | 1 | CCDS81777 | Select | protein_coding | 30 | Yes | 5484 | NM_001330588 |
202 | ENST00000376065.8 | CCDS9502 | protein_coding | 29 | No | 3931 | NM_001367947,NM_003291 |
Published variants
Found 0 variants
Var.name | Exon/Intron | cDNA_pos. | CDS_change | Prot.change | Var.type | Var.class. | Patients |
---|
Please mind that full curation (inclusion of all published variants) of this gene has not started yet. Please contact us if you want to volunteer.
Diagnostic pitfalls & paradigms
Considerations to take into account when analyzing this gene
Year | Paradigm ⓘ | PMID | Notes |
---|---|---|---|
- | Regions of Homology | - | |
- | Cryptic splicing | - | Unreported or not recorded in our DB. |
- | Uniparental disomy | - | Unreported or not recorded in our DB. |
- | Mosaicism | - | Unreported or not recorded in our DB. |
- | Incomplete penetrance | - | Unreported or not recorded in our DB. |
- | Di-/oligo-genic inheritance | - | Unreported or not recorded in our DB. |
- | Somatic reversion | - | Unreported or not recorded in our DB. |
References linked to variants in TPP2
ID | Year | Title | Journal | PMID | Variants |
---|